A critical assessment on the role of sentinel node mapping in endometrial cancer.
10.3802/jgo.2015.26.4.252
- Author:
Giorgio BOGANI
1
;
Antonino DITTO
;
Fabio MARTINELLI
;
Mauro SIGNORELLI
;
Stefania PEROTTO
;
Domenica LORUSSO
;
Francesco RASPAGLIESI
Author Information
1. Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy. giorgio.bogani@istitutotumori.mi.it
- Publication Type:Editorial ; Evaluation Studies
- Keywords:
Endometrial Neoplasms;
Hysteroscopic Injection;
Lymph Node Excision;
Sentinel Node
- MeSH:
Endometrial Neoplasms/*pathology/surgery;
Female;
Humans;
Hysteroscopy/methods;
Injections, Intralesional;
Lymph Node Excision/*methods;
Lymphatic Metastasis;
*Sentinel Lymph Node Biopsy/methods
- From:Journal of Gynecologic Oncology
2015;26(4):252-254
- CountryRepublic of Korea
- Language:English
-
Abstract:
Endometrial cancer is the most common gynecologic malignancy in the developed countries. Although the high incidence of this occurrence no consensus, about the role of retroperitoneal staging, still exists. Growing evidence support the safety and efficacy of sentinel lymph node mapping. This technique is emerging as a new standard for endometrial cancer staging procedures. In the present paper, we discuss the role of sentinel lymph node mapping in endometrial cancer, highlighting the most controversies features.
